HIV-1 transmitted drug resistance in latin America and the Caribbean: What do we know?

Latin America and the Caribbean countries have increased the scaling-up of antiretroviral treatment in the last years. The increase of transmitted drug resistance has been feared due to the worrisome indicators associated with the emergence of drug resistance and monitored by the World Health Organi...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2012

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23952

Acceso en línea:

https://repository.urosario.edu.co/handle/10336/23952

Palabra clave:

Nevirapine
Nonnucleoside reverse transcriptase inhibitor
Zidovudine
Blood toxicity
Brazil
Cd4 lymphocyte count
Central america
Follow up
Gene mutation
Gene sequence
Geographic distribution
Heterosexual male
Highly active antiretroviral therapy
Human
Human immunodeficiency virus 1 infection
Mexico
Prevalence
Rash
Review
Risk factor
Socioeconomics
South and central america
Venezuela
Virus transmission
World health organization
Caribbean region
Female
Guidelines as topic
Hiv infections
Hiv-1
Humans
Latin america
Male
Prevalence
Caribbean
Drug resistance
Genotype
Hiv-1
Latin america
Naive
viral
missense
Drug resistance
Mutation

Rights

License

Abierto (Texto Completo)